Tetraarsenic Hexoxide and Its Effects on Human Leukemic Cells
Author Information
Author(s): Han Min Ho, Lee Won Sup, Lu Jing Nan, Yun Jeong Won, Kim GonSup, Jung Jin Myung, Kim Gi-Young, Lee Su-Jae, Kim Wun-Jae, Choi Yung Hyun
Primary Institution: Dongeui University College of Oriental Medicine
Hypothesis
The study investigates the anticancer activities of Tetraarsenic Hexoxide (As4O6) on apoptosis and autophagy in U937 human leukemic cells.
Conclusion
As4O6 induces both Beclin-1-induced autophagic cell death and caspase-dependent apoptosis in U937 human leukemic cells.
Supporting Evidence
- As4O6 treatment inhibited the growth of U937 cells in a dose- and time-dependent manner.
- The IC50 for As4O6 was found to be less than 2 μM.
- As4O6 induced significant apoptosis as evidenced by DAPI staining showing condensed and fragmented nuclei.
- Caspase activity assays indicated that As4O6 increased proteolytic activities of caspases.
- Western blotting showed that As4O6 increased the expression of Beclin-1 and LC3, markers of autophagy.
Takeaway
Tetraarsenic Hexoxide can help kill cancer cells by making them die in two different ways: one way is like a programmed cell death, and the other way is by recycling parts of the cell.
Methodology
U937 human leukemic cells were treated with various concentrations of As4O6, and cell viability, apoptosis, and autophagy were assessed using MTT assay, DAPI staining, flow cytometry, and Western blotting.
Limitations
The study results are derived from a single leukemic cell line, making it difficult to generalize the findings to all leukemic cells.
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website